Use of anti-CTLA-4 antibodies

Details for Australian Patent Application No. 2006203397 (hide)

Owner Pfizer Products Inc.

Inventors Mueller, Eileen Elliott; Hanson, Douglas Charles

Agent Shelston IP

Pub. Number AU-A-2006203397

Parent 42421

Filing date 7 August 2006

Wipo publication date 7 September 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

24 August 2006 Complete Application Filed

7 September 2006 Application Open to Public Inspection

  Published as AU-A-2006203397

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203398-Aqueous dispersion of polymeric particles

2006203396-Bulkabag regulator